Perrigo Newsroom

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsNov 7 09:35 ET

J.P. Morgan Maintains Perrigo(PRGO.US) With Buy Rating, Cuts Target Price to $38

Moomoo NewsOct 21 08:36 ET

Perrigo Company (PRGO) Receives a Buy From J.P. Morgan

TipRanksOct 21 08:10 ET

Perrigo Is Maintained at Buy by Canaccord Genuity

Dow JonesSep 30 11:35 ET

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsSep 30 07:33 ET

Buy Rating and $42 Target on Perrigo: Strategic Shift and Cost-Saving Initiatives Poised to Drive Margin Expansion

TipRanksSep 30 07:11 ET

Perrigo Analyst Ratings

BenzingaSep 23 17:50 ET

Piper Sandler Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsSep 23 07:31 ET

Perrigo Company (PRGO) Gets a Buy From Piper Sandler

TipRanksSep 23 06:48 ET

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 08:42 ET

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsAug 20 07:31 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Perrigo Company (PRGO), Cue Biopharma (CUE) and United Therapeutics (UTHR)

TipRanksAug 20 07:06 ET

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $42

Moomoo NewsAug 15 07:34 ET

CCORF Maintains Perrigo(PRGO.US) With Buy Rating, Announces Target Price $42

Moomoo NewsJul 30 07:45 ET

Perrigo's Market Advantage and Operational Upside Prompt Buy Rating

TipRanksJul 30 07:04 ET

CCORF Maintains Perrigo(PRGO.US) With Buy Rating

Moomoo NewsJul 24 07:38 ET

Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating

MT NewswiresJul 11 10:18 ET

Perrigo Analyst Ratings

BenzingaJul 11 07:54 ET

Analysts Offer Insights on Healthcare Companies: Perrigo Company (PRGO) and CVRx (CVRX)

TipRanksJul 11 07:14 ET

Piper Sandler Sticks to Their Buy Rating for Perrigo Company (PRGO)

TipRanksJul 11 06:57 ET